Alpha 2.0
Login Register
» Authors » Paul Barriere

Paul Barriere

Explore the profile of Paul Barriere including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 718
Followers 0
Related Specialties
Reproductive Medicine
Gynecology & Obstetrics
Genetics
Top 10 Co-Authors
Thomas Freour
Arnaud Reignier
Miguel Jean
Jenna Lammers
Tiphaine Lefebvre
Sophie Mirallie
Lionel Dessolle
Damien Masson
Florence Leperlier
Catherine Avril
Published In
Reprod Biomed Online
Eur J Obstet Gynecol Reprod Biol
Hum Reprod
J Assist Reprod Genet
J Gynecol Obstet Hum Reprod
Affiliations
Soon will be listed here.
Recent Articles
1.
Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France"
Lehmann M, Pouly J, Barriere P, Boland L, Bean S, Jenkins J
Eur J Obstet Gynecol Reprod Biol X . 2024 Sep; 23:100331. PMID: 39220093
No abstract available.
2.
Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France
Lehmann M, Arbo E, Pouly J, Barriere P, Boland L, Bean S, et al.
Eur J Obstet Gynecol Reprod Biol X . 2024 May; 22:100311. PMID: 38741750
Objective: The study assessed cost-effectiveness of follitropin alfa biosimilar versus the originator in terms of cost per cumulative live-birth (CLB) for the French healthcare system based on real-world evidence. Follitropin...
3.
Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF/ICSI procedures (DELTA Study)
Porcu-Buisson G, Maignien C, Swierkowski-Blanchard N, Rongieres C, Ranisavljevic N, Oger P, et al.
Eur J Obstet Gynecol Reprod Biol . 2023 Dec; 293:21-26. PMID: 38100937
Objective: To describe the use, efficacy and safety profile of follitropin delta in women undergoing IVF/ICSI in routine clinical practice after one treatment cycle. Study Design: This was a French...
4.
Reply to the letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by S. Montenegro, C. Helwig, J.-E. Schwarze, C. Castello-Bridoux, S....
Barriere P, Arbo E, Jenkins J
J Gynecol Obstet Hum Reprod . 2023 Aug; 52(8):102644. PMID: 37573940
No abstract available.
5.
Assisted reproductive techniques do not impact late neurodevelopmental outcomes of preterm children
Lefebvre T, Flamant C, Olivier M, Gascoin G, Bouet P, Roze J, et al.
Front Pediatr . 2023 Jul; 11:1123183. PMID: 37404562
Objective: Assisted reproductive technology (ART) increases the rate of preterm births, though few studies have analyzed outcomes for these infants. No data are available on 4-year-old children born prematurely after...
6.
Correction to: Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer
Grzegorczyk-Martin V, Roset J, Di Pizio P, Freour T, Barriere P, Pouly J, et al.
J Assist Reprod Genet . 2023 Jan; 40(2):429. PMID: 36652119
No abstract available.
7.
Impact of the duration of oestradiol treatment on live birth rate in Hormonal Replacement Therapy cycle before frozen blastocyst transfer
Joly J, Goronflot T, Reignier A, Rosselot M, Leperlier F, Barriere P, et al.
Hum Fertil (Camb) . 2023 Jan; 26(5):1256-1263. PMID: 36594497
Although the duration of progesterone administration in Hormonal Replacement Therapy (HRT) cycles before frozen embryo transfer is standardized, the optimal duration of oestrogen treatment remains controversial. In this monocentric retrospective...
8.
Sexual function in heterosexual couples undergoing assisted reproductive technology (ART) cycles with donor sperm
Le Goff J, Reignier A, Mirallie S, Dubourdieu S, Barriere P, Freour T, et al.
Arch Gynecol Obstet . 2022 Dec; 307(2):625-632. PMID: 36480033
Purpose: Sexuality and the desire for children are closely linked, and infertility can increase the risk of sexual dysfunction (SD). Among heterosexual infertile couples undergoing assisted reproductive technology (ART) cycles,...
9.
A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose
Barriere P, Hamamah S, Arbo E, Avril C, Salle B, Pouly J, et al.
J Gynecol Obstet Hum Reprod . 2022 Nov; 52(1):102510. PMID: 36403900
Background: Since the first launch of a biosimilar recombinant follicle stimulating hormone (rFSH), Bemfola®, in Europe in 2014, it has been possible to study in routine clinical care throughout France...
10.
Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer
Grzegorczyk-Martin V, Roset J, Di Pizio P, Freour T, Barriere P, Pouly J, et al.
J Assist Reprod Genet . 2022 Jun; 39(8):1937-1949. PMID: 35767167
Purpose: To dynamically assess the evolution of live birth predictive factors' impact throughout the in vitro fertilization (IVF) process, for each fresh and subsequent frozen embryo transfers. Methods: In this...